Oxford Biomedica plc (FRA:OXOA)
Germany · Delayed Price · Currency is EUR 9.45
-0.25 (-2.58%)
At close: Jan 30, 2026
Oxford Biomedica Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -37.07 | -43.19 | -157.49 | -39.16 | 19.01 | -6.25 |
Depreciation & Amortization | 20.55 | 20.09 | 21.51 | 20.29 | 12.46 | 9.84 |
Other Amortization | 3.57 | 2.34 | 7.2 | 6.66 | - | - |
Loss (Gain) From Sale of Assets | 0.2 | 0.29 | -0.82 | -21.33 | - | - |
Asset Writedown & Restructuring Costs | 0.18 | 0.18 | 99.29 | - | - | - |
Loss (Gain) From Sale of Investments | - | - | - | 0.05 | 0.17 | 0.83 |
Stock-Based Compensation | 3.27 | 1.69 | 3.52 | 6.47 | 3.98 | 3.29 |
Other Operating Activities | 11.81 | 2.32 | -19.17 | 9.5 | 2.75 | 7.56 |
Change in Accounts Receivable | -29.48 | -33.34 | 28.79 | -17.88 | 6.89 | -25.89 |
Change in Inventory | 0.98 | 2.19 | -0.25 | 0.67 | -2.61 | -4.33 |
Change in Accounts Payable | -3.92 | 2.89 | -18.13 | 16.96 | -0.66 | 5.42 |
Change in Unearned Revenue | 22.3 | -6.05 | 7.03 | 5.16 | -16.53 | 12.62 |
Change in Other Net Operating Assets | -0.23 | -0.08 | 0 | - | - | 0.04 |
Operating Cash Flow | -7.84 | -50.67 | -28.52 | -12.62 | 25.46 | 3.12 |
Operating Cash Flow Growth | - | - | - | - | 716.91% | - |
Capital Expenditures | -4.19 | -7.5 | -9.83 | -16.3 | -9.46 | -13.36 |
Sale of Property, Plant & Equipment | -0.44 | - | 8.39 | 60 | - | - |
Cash Acquisitions | - | 9 | - | -99.21 | - | - |
Investment in Securities | - | - | - | - | - | 2.52 |
Other Investing Activities | 2.74 | 4.12 | 4.25 | -0.96 | - | 0.03 |
Investing Cash Flow | -1.89 | 5.63 | 2.81 | -56.46 | -9.46 | -10.8 |
Long-Term Debt Issued | - | - | - | 64.87 | - | - |
Long-Term Debt Repaid | - | -5.19 | -3.12 | -32.54 | -4.52 | -0.29 |
Net Debt Issued (Repaid) | -3.98 | -5.19 | -3.12 | 32.32 | -4.52 | -0.29 |
Issuance of Common Stock | 0.63 | 17.53 | 0.65 | 80.15 | 51.6 | 41.06 |
Other Financing Activities | -13.68 | -9.43 | -10.24 | -13.85 | -0.87 | -2.58 |
Financing Cash Flow | -17.03 | 2.91 | -12.7 | 98.62 | 46.21 | 38.19 |
Foreign Exchange Rate Adjustments | -0.77 | -0.94 | 0.85 | 2.8 | - | - |
Net Cash Flow | -27.53 | -43.07 | -37.57 | 32.34 | 62.2 | 30.5 |
Free Cash Flow | -12.03 | -58.16 | -38.35 | -28.91 | 15.99 | -10.24 |
Free Cash Flow Margin | -7.95% | -45.16% | -42.83% | -20.65% | 11.20% | -11.68% |
Free Cash Flow Per Share | -0.12 | -0.56 | -0.40 | -0.30 | 0.19 | -0.13 |
Cash Interest Paid | 11.68 | 9.43 | 10.24 | 7.68 | 0.87 | 0.86 |
Cash Income Tax Paid | - | - | -7.51 | -0.56 | -0.99 | -7.01 |
Levered Free Cash Flow | -11.15 | -34.85 | -17.07 | -12.82 | 10.88 | -6.82 |
Unlevered Free Cash Flow | -3.63 | -28.7 | -10.4 | -7.98 | 11.42 | -6.27 |
Change in Working Capital | -10.35 | -34.38 | 17.46 | 4.91 | -12.91 | -12.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.